Anti-Malarial Drugs Market, By Drug Class (Aminoquinolines, Quinoline-Methanol (4-Quinolinemethanols

Published Date: | Report Code : HC2067634


Anti-Malarial Drugs Market, By Drug Class (Aminoquinolines, Quinoline-Methanol (4-Quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides And Sulfones, And Others), By Route Of Administration (Oral And Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), By Region (North America, Europe, Asia Pacific, Middle East & Africa, And South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2067634

Status : Upcoming

The Anti-malarial Drugs Market report points out national and global business prospects and competitive conditions for anti-malarial drugs. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for anti-malarial drugs. The anti-malarial drugs market has been segmented by drug class (aminoquinolines, quinoline-methanol (4-quinolinemethanols), cinchona alkaloids, biguanides, sulfonamides and sulfones, and others), by route of administration (oral and injectable), by distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies). Historical background for the demand of anti-malarial drugs has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand anti-malarial drugs have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Drug Class:   

  • Lateral Flow Based Assays
  • Enzyme Label
  • Microfluidics
  • Biochips
  • Biosensors
  • Others

By Route of Administration:

  • Diagnostic and Monitoring
  • Drug Development
  • Quality Testing

By Distribution Channel:

  • Hospitals, Clinics
  • Laboratories
  • Home Care Settings
  • Others

By Region:

North America Anti-malarial Drugs Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Drug Class
  • North America, by Route of Administration
  • North America, by Distribution Channel

Europe Anti-malarial Drugs Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Drug Class
  • Europe, by Route of Administration
  • Europe, by Distribution Channel

Asia Pacific Anti-malarial Drugs Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Drug Class
  • Asia Pacific, by Route of Administration
  • Asia Pacific, by Distribution Channel

Middle East & Africa Anti-malarial Drugs Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Drug Class
  • Middle East & Africa, by Route of Administration
  • Middle East & Africa, by Distribution Channel

South America Anti-malarial Drugs Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Drug Class
  • South America, by Route of Administration
  • South America, by Distribution Channel

Major Companies: Zydus Cadila, Merck KGaA Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, and Roche Inc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for anti-malarial drugs market on regional and global basis.
  • To identify major segments in anti-malarial drugs market and evaluate their market shares and demand.
  • To provide a competitive scenario for the anti-malarial drugs market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of anti-malarial drugs market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the anti-malarial drugs market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the anti-malarial drugs


This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: [email protected]


License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy